(R)-(4,4-bis(3-methyl-2-thienyl)-3-butenyl)-3-piperidinecarboxylic acid, hydrochloride,
Gabitril,
N-(4,4-di(3-methylthien-2-yl)but-3-enyl)nipecotic acid,
NO 328,
NO 329,
NO-328,
NO-329,
tiagabine,
Tiagabine Hydrochloride,
tiagabine, (S)-isomer,
Tiagabine hydrochloride,
145821-59-6,
TIAGABINE HCl,
Gabitril,
Abbott 70569.HCl,
NNC-05-0328,
Tiagabine (hydrochloride),
UNII-DQH6T6D8OY,
Abbott-70569.1,
TGB hydrochloride,
NO-05-0328,
Gabitril hydrochloride,
NO328 hydrochloride,
ABT 569,
DQH6T6D8OY,
NO050328 hydrochloride,
ABT-569,
ABBOTT-70569.HCL,
(r)-1-(4,4-bis(3-methylthiophen-2-yl)but-3-en-1-yl)piperidine-3-carboxylic acid hydrochloride,
CHEBI:85388,
MFCD07369025,
Gabitril (TN),
(-)-(R)-1-(4,4-Bis(3-methyl-2-thienyl)-3-butenyl)nipecotic acid, hydrochloride,
(-)-(R)-1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]nipecotic acid hydrochloride,
(3R)-1-[4,4-bis(3-methylthiophen-2-yl)but-3-enyl]piperidine-3-carboxylic acid hydrochloride,
DSSTox_CID_24218,
DSSTox_RID_80125,
DSSTox_GSID_44218,
(3R)-1-[4,4-Bis(3-methyl-2-thienyl)-3-buten-1-yl]-3-piperidinecarboxylic acid hydrochloride,
(3R)-1-[4,4-bis(3-methylthiophen-2-yl)but-3-en-1-yl]piperidine-3-carboxylic acid hydrochloride,
3-Piperidinecarboxylic acid, 1-(4,4-bis(3-methyl-2-thienyl)-3-buten-yl)-, hydrochloride, (R)-,
3-Piperidinecarboxylic acid, 1-(4,4-bis(3-methyl-2-thienyl)-3-butenyl)-, hydrochloride, (R)-,
CAS-145821-59-6,
NO-328,
NCGC00164626-01,
Tiabex,
Tiagabine hydrochloride [USAN],
(-)-(R)-1-(4,4-bis(3-methyl-2-thienyl)-3-butenyl)nipecotic acid hydrochloride,
AK155448,
Tiagabine hydrochloride [USAN:USP],
(R)-1-(4,4-bis(3-methylthiophen-2-yl)but-3-enyl)piperidine-3-carboxylic acid hydrochloride,
tiagabine monohydrochloride,
AC1L3LR1,
CHEMBL1695,
C20H26ClNO2S2,
SCHEMBL41860,
C20H25NO2S2.HCl,
MLS001401367,
Tiagabine hydrochloride (USP),
Tiagabine hydrochloride, 98+%,
DTXSID2044218,
HY-B0696A,
(3R)-1-[4,4-Bis(3-methyl-2-thienyl)-3-butenyl]-3-piperidinecarboxylic Acid Hydrochloride,
YUKARLAABCGMCN-PKLMIRHRSA-N,
(3R)-1-[4,4-bis(3-methylthiophen-2-yl)but-3-enyl]piperidine-3-carboxylic acid;hydrochloride,
CEP-6671,
KS-00000H6B,
Tox21_112245,
BG0438,
NN-301,
s4661,
AKOS024258856,
Tox21_112245_1,
API0004405,
CCG-100885,
CS-2937,
H03T543,
KS-1217,
NC00135,
VC30712,
NCGC00164626-02,
AN-31388,
CPD000469176,
SAM001246625,
SMR000469176,
Tiagabine hydrochloride, >=98% (HPLC),
AX8154082,
LS-173258,
ST2402069,
4CH-019728,
FT-0675216,
D02097,
EN300-221591,
A-70569,
J-008159,
Z2216208631,
Tiagabine Hydrochloride 1.0 mg/ml in Methanol (as free base),
(-)-(R)-1-[4,4-Bis(3- methyl-2-thienyl)-3-butenyl]nipecotic acid hydrochloride,
(3R)-1-[4,4-bis(3-methyl-2-thienyl)but-3-en-1-yl]-3-carboxypiperidinium chloride,
(3R)-1-[4,4-bis(3-methyl-2-thienyl)but-3-enyl]piperidine-3-carboxylic acid hydrochloride,
(3R)-1-[4,4-bis(3-methyl-2-thienyl)but-3-en-1-yl]piperidine-3-carboxylic acid hydrochloride,
(3R)-1-[4,4-bis(3-methyl-2-thienyl)but-3-en-1-yl]piperidine-3-carboxylic acid monohydrochloride,
3-Piperidinecarboxylic acid, 1-[4,4-bis(3-methyl-2-thienyl)-3-buten-1-yl]-, hydrochloride (1:1), (3R)-,
Tiagabine hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material,
tiagabine,
Tiagabinehydrochloride,
Abbott-70569,
C20H25NO2S2.ClH,
CID91274,
C20-H25-N-O2-S2.Cl-H,
ACN-034424,
CS-T-44344,
T3165,
Tiagabine hydrochloride, 99% - 250MG 250mg,
115103-54-3,